About AGA
About AGA
Menu
AGA Corporate Roundtable
The AGA Corporate Roundtable engages corporate partners and AGA leadership in dialogue regarding innovations in practice, clinical and research advances, public policy, and other issues that impact the future of gastroenterology and hepatology care. Our goal is to work together to better serve the GI community and improve care for digestive disease patients.
2024-2025 AGA Corporate Roundtable Members
Thank you to our corporate roundtable members for your shared commitment to advancing GI. Roundtable fees support the AGA Research Foundation.
GOLD SUPPORTERS
- AbbVie
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly and Company
- Exact Sciences
- Medtronic
- Pfizer, Inc.
- Salix Pharmaceuticals
- Takeda Pharmaceuticals U.S.A., Inc.
SILVER SUPPORTERS
- Amgen
- Boston Scientific
- Genentech, Inc
- Ironwood Pharmaceuticals
- Johnson & Johnson Health Care Systems, Inc.
- Merck & Co., Inc.
- Novo Nordisk
- Sandoz
As of Nov. 14, 2024.
AGA Corporate Roundtable membership information
Membership to the corporate roundtable supports the AGA Research Foundation. Benefits of participation in the roundtable include:
- Access to AGA leadership and other industry leaders.
- Up to date information on the latest news in the field.
- Opportunity to share your insights and opinions.
- Visibility at DDW events.
- Recognition in AGA communications including journals, website and newsletters
